Metformin: An anti-diabetic drug to fight cancer.

Abstract

Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer incidence and mortality, many in vitro and in vivo studies as well as a large number of clinical trials have been conducted in order to study its potential. The many anticancer actions of metformin lead to a cytostatic effect. Two distinct but not exclusive… (More)
DOI: 10.1016/j.phrs.2016.10.006

Topics

  • Presentations referencing similar topics